BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Gross Profit
BRAIN Biotech AG
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Gross Profit
€31m
|
CAGR 3-Years
15%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Gross Profit
€1.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Evonik Industries AG
XETRA:EVK
|
Gross Profit
€4.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Covestro AG
XETRA:1COV
|
Gross Profit
€2.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Gross Profit
€308.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Gross Profit
€1.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
See Also
What is BRAIN Biotech AG's Gross Profit?
Gross Profit
31m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Gross Profit amounts to 31m EUR.
What is BRAIN Biotech AG's Gross Profit growth rate?
Gross Profit CAGR 5Y
6%
Over the last year, the Gross Profit growth was 5%. The average annual Gross Profit growth rates for BRAIN Biotech AG have been 15% over the past three years , 6% over the past five years .